MEDICO REMEDIES LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 45.21 INR | -0.68% |
|
-4.80% | -45.91% |
| Sales 2022 | 1.21B 14.51M 1.16B | Sales 2023 | 1.4B 16.84M 1.34B | Capitalization | 6.2B 74.31M 5.93B |
|---|---|---|---|---|---|
| Net income 2022 | 48M 575K 45.9M | Net income 2023 | 72M 863K 68.85M | EV / Sales 2022 | 1.22 x |
| Net Debt 2022 | 82.7M 991K 79.08M | Net Debt 2023 | 75.84M 909K 72.53M | EV / Sales 2023 | 4.47 x |
| P/E ratio 2022 |
28.5
x | P/E ratio 2023 |
85.6
x | Employees | 150 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 16.72% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.68% | ||
| 1 week | -4.80% | ||
| Current month | -8.26% | ||
| 1 month | -7.20% | ||
| 3 months | -46.43% | ||
| 6 months | -36.76% | ||
| Current year | -45.91% |
1 week
44.21
48.00
1 month
44.2149.70
Current year
44.2191.97
1 year
44.21100.79
3 years
5.65100.79
5 years
3.35100.79
10 years
3.35100.79
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 36 | 13/12/11 | |
| Chairman | 63 | 17/03/94 | |
Gopal Jha
ADM | Chief Administrative Officer | - | 30/09/02 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chairman | 63 | 17/03/94 | |
| Chief Executive Officer | 36 | 13/12/11 | |
| Director/Board Member | 60 | 07/12/99 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/05/24 | 45.21 | -0.68% | 27 509 |
| 30/04/24 | 45.52 | -0.91% | 7,073 |
| 29/04/24 | 45.94 | -1.31% | 10,140 |
| 26/04/24 | 46.55 | -0.73% | 8,312 |
| 25/04/24 | 46.89 | -1.14% | 5,912 |
Delayed Quote Bombay S.E., May 02, 2024 at 11:00 am
More quotes
Medico Remedies Limited is an India-based pharmaceutical formulation manufacturing company. The Company is engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. It has manufacturing and marketing capabilities in formulation with focus on anti-infective, Beta-Lactums, cephalosporins, antimalarial, antiretroviral, anti-ulcer drugs and antacids, vitamins, haematinics and other supplements. In addition, the Company also manufactures other drugs, such as non-steroidal anti-inflammatory drugs (NSAIDS), antihistaminic, anti-diabetics, cardiovascular drugs, diuretics, anti-epileptics, combination drug kits, syrups and cream, and gel for various therapeutic segments. Its products include Doxycycline Capsules, Zenof-400 (Ofloxacin Tablets 400mg), Azithromycin Tablets, Aciclovir Tablets, Cipta Tablets, Cotrimoxazole Tablets, Tos Syrup, Paediatric Co-Trimozole Oral, Med Reactin (Cyproheptadine), and Medivit Syrup, among others.
Sector
Pharmaceuticals
Calendar
29/05/2024
- Q4 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -45.91% | 45.25M | |
| +29.68% | 699B | |
| +25.07% | 571B | |
| -4.35% | 364B | |
| +17.65% | 326B | |
| +3.77% | 286B | |
| +14.68% | 236B | |
| +4.71% | 198B | |
| -12.43% | 194B | |
| -3.79% | 154B |
- Stock Market
- Equities
- MEDICO Stock
